Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("14-3-3σ")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 13 of 13

  • Page / 1
Export

Selection :

  • and

Vitamin C induces apoptosis in AGS cells by down-regulation of 14―3-3σ via a mitochondrial dependent pathwayNAGAPPAN, Arulkumar; KWANG IL PARK; GON SUP KIM et al.Food chemistry. 2012, Vol 135, Num 3, pp 1920-1928, issn 0308-8146, 9 p.Article

COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σCHOI, H. H; GULLY, C; YEUNG, S. C et al.Oncogene (Basingstoke). 2011, Vol 30, Num 48, pp 4791-4801, issn 0950-9232, 11 p.Article

14-3-3σ-Dependent Resistance to CisplatinZHIYONG HAN; DIMAS, Konstantinos; WYCHE, James H et al.Anticancer research. 2009, Vol 29, Num 6, pp 2009-2014, issn 0250-7005, 6 p.Article

Prognostic significance of 14-3-3σ expression in oral squamous cell carcinoma (OSCC)LAIMER, Klaus; BLASSNIG, Nicola; SPIZZO, Gilbert et al.Oral oncology (1997). 2009, Vol 45, Num 2, pp 127-134, issn 1368-8375, 8 p.Article

Distribution and significance of 14-3-3σ, a novel myoepithelial marker, in normal, benign, and malignant breast tissueSIMPSON, Peter T; GALE, Theodora; REIS-FILHO, Jorge S et al.Journal of pathology. 2004, Vol 202, Num 3, pp 274-285, issn 0022-3417, 12 p.Article

Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancersOSADA, Hirotaka; TATEMATSU, Yoshio; YATABE, Yasushi et al.Oncogene (Basingstoke). 2002, Vol 21, Num 15, pp 2418-2424, issn 0950-9232, 7 p.Article

14-3-3σ expression as a prognostic marker in undifferentiated nasopharyngeal carcinomaCHAN, Sylvia Yat-Yee; TO, Ka-Fai; LEUNG, Sing-Fai et al.Oncology reports. 2010, Vol 24, Num 4, pp 949-955, issn 1021-335X, 7 p.Article

Expression of 14-3-3σ in cervical squamous cell carcinomas: Relationship with clinical outcomeHOLM, Ruth; ALI, Tayeba; SVENDSRUD, Debbie H et al.Oncology reports. 2009, Vol 22, Num 1, pp 11-15, issn 1021-335X, 5 p.Article

14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancersNAKAMURA, Yukiko; OSHIMA, Kazuteru; NAOI, Yasuto et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 229-236, issn 0167-6806, 8 p.Article

Decreased expression of 14-3-3σ in neuroendocrine tumors is independent of origin and malignant potentialYATABE, Yasushi; OSADA, Hirotaka; TATEMATSU, Yoshio et al.Oncogene (Basingstoke). 2002, Vol 21, Num 54, pp 8310-8319, issn 0950-9232, 10 p.Article

S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasiaKAUR, Jatinder; MATTA, Ajay; WALFISH, Paul G et al.International journal of cancer (Print). 2014, Vol 134, Num 6, pp 1379-1388, issn 0020-7136, 10 p.Article

Association of TSC1/Hamartin, 14-3-3σ, and p27 Expression With Tumor Outcomes in Patients With pTa/pT1 Urothelial Bladder CarcinomaMHAWECH-FAUCEGLIA, Paulette; ALVAREZ, Victor; FISCHER, Gabor et al.American journal of clinical pathology. 2008, Vol 129, Num 6, pp 918-923, issn 0002-9173, 6 p.Article

Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysisGUOPEI ZHENG; FANG PENG; RENKUI DING et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 10, pp 1477-1488, issn 0171-5216, 12 p.Article

  • Page / 1